Stocks · News reference
Galmed Pharmaceuticals shares are trading higher after the company announced a corporate rebranding to Eocene and a change in the trading symbol of the Company on the Nasdaq to "EOCN."
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Galmed Pharmaceuticals shares are trading higher after the company's subsidiary Colospan announced the completion of a feasibility study supporting the development of a novel intraoperative colon tissue quality assessment platform.
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times